Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Oncolytics completes patient enrollment in REOLYSIN trial to treat metastatic colorectal cancer

Oncolytics Biotech Inc. announced today that enrollment has been completed in a U.K. translational clinical trial investigating intravenous administration of REOLYSIN in patients with metastatic colorectal cancer prior to surgical resection of liver metastases.

23 Feb 2011

Red and processed meats – How much to include in diet?

A latest Government-commissioned report advises people to eat less red meat and processed meat saying that it lowers the risk of developing cancer. The report will advise consumers eat no more than 2.5 oz (70g) of red or processed meat a day – the equivalent of three rashers of bacon. Also the weekly recommended limit is likely to be 1.1 lb (500g), the same as eating a large pack of minced beef, two 8oz steaks or four 4oz pork chops. The farming and retail industries are, as predictable, not happy with the directives.

22 Feb 2011

Two researchers receive Brupbacher Prize for Cancer Research 2011

Today, the Charles Rodolphe Brupbacher Prize for Cancer Research 2011 goes to two researchers who have contributed to better understanding of the genetics underlying the growth of tumors.

17 Feb 2011

Astellas, AVEO enter development, commercialization agreement for tivozanib

Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.

17 Feb 2011

Passion for dancing helps beat breast cancer

When Karen Franklin was diagnosed with breast cancer last year, it was her passion for Zumba® that helped her beat the disease. Franklin's story, say experts at The University of Texas MD Anderson Cancer Center, reminds us about exercise's cancer-fighting benefits.

16 Feb 2011

Novel molecular approach using biomarker can predict colorectal cancer staging, recurrence

A quantitative, molecular analysis of lymph nodes in patients deemed colorectal cancer-free was found to be an effective predictor of recurrence, according to a study from researchers at the Kimmel Cancer Center at Jefferson and published online Feb 9. in Clinical Cancer Research.

16 Feb 2011

Bisphosphonates appear to reduce risk of postmenopausal colorectal cancer by 50%

An international team of researchers has found that the use of bisphosphonates - drugs already taken by millions of healthy women to prevent bone-loss - for more than one year was associated with a 50 percent reduction in the risk of postmenopausal colorectal cancer. The results were published this week in the Journal of Clinical Oncology.

15 Feb 2011

NHGRI's new strategic plan to identify genetic bases of most single-gene disorders

A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).

14 Feb 2011

Research roundup: Access to care in Mass.; Mental health spending; Gender and medical debt: How much do Americans know about health law?

Health Affairs: Lack Of Access Due To Costs Remains A Problem For Some In Massachusetts Despite The State's Health Reforms - Based on an analysis of state data, the authors found that the percentage of people without insurance fell "to twelve-year lows in Massachusetts, from 11.5 percent (SE 0.91) in 1996 to 3.5 percent (SE 0.33) in 2008.

11 Feb 2011

Aushon BioSystems enters diagnostic development collaboration with Peking University Cancer Hospital

Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services announced that it has signed a letter of intent to enter into a diagnostic development collaboration with Peking University Cancer Hospital ("PUCH"), Beijing, China.

9 Feb 2011

Study finds link between sleep duration and colorectal adenomas

An inadequate amount of sleep has been associated with higher risks of obesity, heart disease, diabetes, and death. Now colon cancer can be added to the list.

9 Feb 2011

Study estimates 1.3 million cancer deaths in Europe in 2011

There will be nearly 1.3 million deaths from cancer in Europe in 2011 according to predictions from a study published in the cancer journal, Annals of Oncology today.

8 Feb 2011

More than 6% of bowel cancer patients in Scotland died within 30 days of diagnosis

More than six per cent of bowel cancer patients in Scotland died within 30 days of diagnosis according to new research published in the British Journal of Cancer.

8 Feb 2011

Study finds heartburn as a common condition in Iceland

Heartburn is a signature symptom of gastroesophageal reflux disease (GERD), which is a cluster of symptoms and signs associated with regurgitation of stomach acid up to the pharynx and mouth. Patient-based studies of GERD have shown high prevalence and chronicity, particularly in Western societies. GERD is associated with significant health-care utilization and diminished quality of life.

8 Feb 2011

Fast track rehabilitation program effective after colorectal surgery

The concept of fast track rehabilitation program has been recently introduced in colorectal surgery. It is basically a multidisciplinary perioperative care strategy for patients after resection of colorectal cancer.

8 Feb 2011

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

Genentech, a member of the Roche Group, announced today that OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and gemcitabine) followed by continued use of Avastin alone until disease progression in women with previously treated (recurrent), platinum-sensitive ovarian cancer, met its primary endpoint.

8 Feb 2011

Study on non-surgical approach for treatment of liver hydatidosis

Concerning treatment, until recently the only definitive treatment for hydatid disease had been surgery. Different surgical techniques and procedures have been carried out and even in some cases, a liver transplant has been required. Advances in drug therapy has been influenced by the introduction of albendazole and accelerated by addition of praziquantel, but this requires a long period of treatment i.e. up to a year or more, and is not effective for everyone.

8 Feb 2011

U-M Medical School earns $368.7 million in NIH research funding during federal fiscal year 2010

University of Michigan Medical School physicians and scientists earned more than $368.7 million in National Institutes of Health research funding in federal fiscal year 2010, according to NIH data. In all, the School's faculty brought in $481.8 million in research funding from all sources in U-M fiscal year 2010.

5 Feb 2011

American Cancer Society report released on World Cancer Day

A new American Cancer Society report says cancers associated with lifestyles and behaviors related to economic development, including lung, breast, and colorectal cancers, will continue to rise in developing countries if preventive measures are not widely applied. The finding comes from the second edition of Global Cancer Facts & Figures and its academic publication, Global Cancer Statistics, published in CA: A Cancer Journal for Clinicians.

4 Feb 2011

New concrete actions on cancer prevention in Europe

ECCO and its partners are joining forces with the European Commission and MEPs to put forward concrete actions on cancer prevention, to national and EU policymakers in Brussels on 2 February, ahead of World Cancer Day on 4 February.

3 Feb 2011

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Oncolytics completes patient enrollment in REOLYSIN trial to treat metastatic colorectal cancer

Red and processed meats – How much to include in diet?

Two researchers receive Brupbacher Prize for Cancer Research 2011

Astellas, AVEO enter development, commercialization agreement for tivozanib

Passion for dancing helps beat breast cancer

Novel molecular approach using biomarker can predict colorectal cancer staging, recurrence

Bisphosphonates appear to reduce risk of postmenopausal colorectal cancer by 50%

NHGRI's new strategic plan to identify genetic bases of most single-gene disorders

Research roundup: Access to care in Mass.; Mental health spending; Gender and medical debt: How much do Americans know about health law?

Aushon BioSystems enters diagnostic development collaboration with Peking University Cancer Hospital

Study finds link between sleep duration and colorectal adenomas

Study estimates 1.3 million cancer deaths in Europe in 2011

More than 6% of bowel cancer patients in Scotland died within 30 days of diagnosis

Study finds heartburn as a common condition in Iceland

Fast track rehabilitation program effective after colorectal surgery

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

Study on non-surgical approach for treatment of liver hydatidosis

U-M Medical School earns $368.7 million in NIH research funding during federal fiscal year 2010

American Cancer Society report released on World Cancer Day

New concrete actions on cancer prevention in Europe

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in